S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Xia Luo · Study
Home
/
Author
Xia Luo
2 works
· latest 2019
· 2 institutions
cluster: provisional
Follow
Claim this profile
h-index
2
i10
2
Citations
153
Works here
2
19
Most cited in this library
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis
2019 · 105 citations
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
2019 · 48 citations
Works
2 shown
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis
Clinical Drug Investigation
·
2019
·
7 authors
·
Open access
48
citations
First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis
Cancer
·
2019
·
6 authors
·
Open access
105
citations